SCHEMBL23309516

SCHEMBL23309516

CCOC(=O)c1ccc(NC(=O)c2cc(F)nc(F)c2F)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.57
▸ KMT2A Q03164 6/20 0.57
▸ SMN1; SMN2 Q16637 5/20 0.57
▸ RAB9A P51151 5/20 0.57
▸ NPC1 O15118 4/20 0.57
▸ GAA P10253 3/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ MAPT P10636 8/20 0.54
▸ CASP3 P42574 2/20 0.54
▸ SENP7 Q9BQF6 2/20 0.54
▸ TRPV1 Q8NER1 1/20 0.54
▸ MAOA P21397 1/20 0.53
▸ TP53 P04637 2/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ MAPK1 P28482 2/20 0.50
▸ TSHR P16473 2/20 0.50
▸ POLB P06746 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309589 0.87 RAB9A (0.63) MEN1KMT2ASMN1; SMN2RAB9ANPC1
SCHEMBL23309730 0.83 KMT2A (0.47) MEN1KMT2ASMN1; SMN2RAB9ANPC1
SCHEMBL23309584 0.83 NPC1 (0.57) MEN1KMT2ASMN1; SMN2RAB9ANPC1
SCHEMBL23309621 0.82 RAB9A (0.50) MEN1KMT2ASMN1; SMN2RAB9ANPC1
SCHEMBL23309544 0.79 TSHR (0.48) MEN1KMT2AALDH1A1MAPTTP53
SCHEMBL23309617 0.79 NPC1 (0.54) MEN1KMT2ASMN1; SMN2RAB9ANPC1
SCHEMBL23309483 0.77 CYP1A2 (0.52) MEN1KMT2ASMN1; SMN2RAB9ANPC1
SCHEMBL23309708 0.77 RAB9A (0.52) KMT2ASMN1; SMN2RAB9ANPC1GAA
SCHEMBL7336402 0.77 MEN1 (0.68) MEN1KMT2ASMN1; SMN2RAB9ANPC1
SCHEMBL23309490 0.76 GAA (0.51) MEN1KMT2ASMN1; SMN2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL MEN1 1633/4885KMT2A 2360/4885SMN1; SMN2 3893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback